Level/ Type |
Code |
Display Name |
Code System |
0‑L |
46233009
|
Influenza virus vaccine (product)
|
SNOMED Clinical Terms |
0‑L |
35736007
|
Cholera vaccine
|
SNOMED Clinical Terms |
0‑L |
421245007
|
Diphtheria + pertussis + tetanus vaccine
|
SNOMED Clinical Terms |
0‑L |
414004005
|
Diphtheria + tetanus + pertussis + poliomyelitis + haemophilus influenzae b vaccine
|
SNOMED Clinical Terms |
0‑L |
414005006
|
Diphtheria + tetanus + pertussis + poliomyelitis vaccine
|
SNOMED Clinical Terms |
0‑L |
350327004
|
Diphtheria + tetanus vaccine
|
SNOMED Clinical Terms |
0‑L |
428214002
|
Diphtheria vaccine
|
SNOMED Clinical Terms |
0‑L |
333680004
|
Haemophilus influenzae Type b vaccine
|
SNOMED Clinical Terms |
0‑L |
14745005
|
Hepatitis A virus vaccine
|
SNOMED Clinical Terms |
0‑L |
333702001
|
Hepatitis A+B vaccine
|
SNOMED Clinical Terms |
0‑L |
34689006
|
Hepatitis B virus vaccine
|
SNOMED Clinical Terms |
0‑L |
424519000
|
Human papillomavirus vaccine
|
SNOMED Clinical Terms |
0‑L |
427036009
|
Influenza virus H5N1 vaccine
|
SNOMED Clinical Terms |
0‑L |
333697005
|
Japanese B encephalitis vaccine
|
SNOMED Clinical Terms |
0‑L |
386012008
|
Measles vaccine
|
SNOMED Clinical Terms |
0‑L |
423531006
|
Meningococcus vaccine
|
SNOMED Clinical Terms |
0‑L |
90043005
|
Mumps live virus vaccine
|
SNOMED Clinical Terms |
0‑L |
61602008
|
Pertussis vaccine
|
SNOMED Clinical Terms |
0‑L |
333598008
|
Pneumococcal vaccine
|
SNOMED Clinical Terms |
0‑L |
111164008
|
Poliovirus vaccine
|
SNOMED Clinical Terms |
0‑L |
333606008
|
Rabies vaccine
|
SNOMED Clinical Terms |
0‑L |
116077000
|
Rotavirus vaccine
|
SNOMED Clinical Terms |
0‑L |
386013003
|
Rubella vaccine
|
SNOMED Clinical Terms |
0‑L |
33234009
|
Smallpox vaccine
|
SNOMED Clinical Terms |
0‑L |
333621002
|
Tetanus vaccine
|
SNOMED Clinical Terms |
0‑L |
333699008
|
Tick-borne encephalitis vaccine
|
SNOMED Clinical Terms |
0‑L |
420538001
|
Tuberculosis vaccine
|
SNOMED Clinical Terms |
0‑L |
89428009
|
Typhoid vaccine
|
SNOMED Clinical Terms |
0‑L |
56844000
|
Yellow fever vaccine
|
SNOMED Clinical Terms |
0‑L |
61153008
|
Measles + Mumps + Rubella vaccine
|
SNOMED Clinical Terms |
0‑L |
108729007
|
Varicella vaccine
|
SNOMED Clinical Terms |
0‑L |
1119305005
|
SARS-CoV-2 antigen vaccine
|
SNOMED Clinical Terms |
0‑L |
1119349007
|
SARS-CoV-2 mRNA vaccine
|
SNOMED Clinical Terms |
0‑L |
J07AC
|
Anthrax vaccines
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AC01
|
anthrax antigen
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AD
|
Brucellosis vaccines
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AD01
|
brucella antigen
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AE
|
Cholera vaccines
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AE01
|
cholera, inactivated, whole cell
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AE02
|
cholera, live attenuated
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AE51
|
cholera, combinations with typhoid vaccine, inactivated, whole cell
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AF
|
Diphtheria vaccines
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AF01
|
diphtheria toxoid
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AG
|
Haemophilus influenzae B vaccines
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AG01
|
haemophilus influenzae B, purified antigen conjugated
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AG51
|
haemophilus influenzae B, combinations with toxoids
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AG52
|
haemophilus influenzae B, combinations with pertussis and toxoids
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AG53
|
haemophilus influenzae B, combinations with meningococcus C, conjugated
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AH
|
Meningococcal vaccines
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AH01
|
meningococcus A, purified polysaccharides antigen
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AH02
|
other meningococcal monovalent purified polysaccharides antigen
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AH03
|
meningococcus A,C, bivalent purified polysaccharides antigen
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AH04
|
meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AH05
|
other meningococcal polyvalent purified polysaccharides antigen
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AH06
|
meningococcus B, outer membrane vesicle vaccine
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AH07
|
meningococcus C, purified polysaccharides antigen conjugated
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AH08
|
meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AH09
|
meningococcus B, multicomponent vaccine
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AH10
|
meningococcus A, purified polysaccharides antigen conjugated
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AJ
|
Pertussis vaccines
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AJ01
|
pertussis, inactivated, whole cell
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AJ02
|
pertussis, purified antigen
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AJ51
|
pertussis, inactivated, whole cell, combinations with toxoids
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AJ52
|
pertussis, purified antigen, combinations with toxoids
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AK
|
Plague vaccines
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AK01
|
plague, inactivated, whole cell
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AL
|
Pneumococcal vaccines
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AL01
|
pneumococcus, purified polysaccharides antigen
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AL02
|
pneumococcus, purified polysaccharides antigen conjugated
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AL52
|
pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AM
|
Tetanus vaccines
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AM01
|
tetanus toxoid
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AM51
|
tetanus toxoid, combinations with diphtheria toxoid
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AM52
|
tetanus toxoid, combinations with tetanus immunoglobulin
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AN
|
Tuberculosis vaccines
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AN01
|
tuberculosis, live attenuated
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AP
|
Typhoid vaccines
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AP01
|
typhoid, oral, live attenuated
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AP02
|
typhoid, inactivated, whole cell
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AP03
|
typhoid, purified polysaccharide antigen
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AP10
|
typhoid, combinations with paratyphi types
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AR
|
Typhus (exanthematicus) vaccines
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AR01
|
typhus exanthematicus, inactivated, whole cell
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07AX
|
Other bacterial vaccines
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BA
|
Encephalitis vaccines
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BA01
|
encephalitis, tick borne, inactivated, whole virus
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BA02
|
encephalitis, Japanese, inactivated, whole virus
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BA03
|
encephalitis, Japanese, live attenuated
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BB
|
Influenza vaccines
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BB01
|
influenza, inactivated, whole virus
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BB02
|
influenza, inactivated, split virus or surface antigen
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BB03
|
influenza, live attenuated
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BB04
|
influenza, virus like particles
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BC
|
Hepatitis vaccines
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BC01
|
hepatitis B, purified antigen
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BC02
|
hepatitis A, inactivated, whole virus
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BC20
|
combinations
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BD
|
Measles vaccines
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BD01
|
measles, live attenuated
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BD51
|
measles, combinations with mumps, live attenuated
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BD52
|
measles, combinations with mumps and rubella, live attenuated
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BD53
|
measles, combinations with rubella, live attenuated
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BD54
|
measles, combinations with mumps, rubella and varicella, live attenuated
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BE
|
Mumps vaccines
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BE01
|
mumps, live attenuated
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BF
|
Poliomyelitis vaccines
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BF01
|
poliomyelitis oral, monovalent, live attenuated
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BF02
|
poliomyelitis oral, trivalent, live attenuated
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BF03
|
poliomyelitis, trivalent, inactivated, whole virus
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BF04
|
poliomyelitis oral, bivalent, live attenuated
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BG
|
Rabies vaccines
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BG01
|
rabies, inactivated, whole virus
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BH
|
Rota virus diarrhea vaccines
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BH01
|
rota virus, live attenuated
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BH02
|
rota virus, pentavalent, live, reassorted
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BJ
|
Rubella vaccines
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BJ01
|
rubella, live attenuated
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BJ51
|
rubella, combinations with mumps, live attenuated
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BK
|
Varicella zoster vaccines
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BK01
|
varicella, live attenuated
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BK02
|
zoster, live attenuated
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BK03
|
zoster, purified antigen
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BL
|
Yellow fever vaccines
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BL01
|
yellow fever, live attenuated
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BM
|
Papillomavirus vaccines
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BM01
|
papillomavirus (human types 6, 11, 16, 18)
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BM02
|
papillomavirus (human types 16, 18)
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BM03
|
papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58)
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BX
|
Other viral vaccines
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BX01
|
smallpox vaccines
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BX02
|
ebola vaccines
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07BX03
|
covid-19 vaccines
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07CA
|
Bacterial and viral vaccines, combined
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07CA01
|
diphtheria-poliomyelitis-tetanus
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07CA02
|
diphtheria-pertussis-poliomyelitis-tetanus
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07CA03
|
diphtheria-rubella-tetanus
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07CA04
|
haemophilus influenzae B and poliomyelitis
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07CA05
|
diphtheria-hepatitis B-pertussis-tetanus
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07CA06
|
diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07CA07
|
diphtheria-hepatitis B-tetanus
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07CA08
|
haemophilus influenzae B and hepatitis B
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07CA09
|
diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07CA10
|
typhoid-hepatitis A
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07CA11
|
diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07CA12
|
diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B
|
WHO Anatomical Therapeutic Chemical classification |
0‑L |
J07CA13
|
diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A
+ C
|
WHO Anatomical Therapeutic Chemical classification |
|